Description
Acebilustat (CTX-4430, EP-501) is a potent and selective leukotriene A4 hydrolase (LTA4H) inhibitor with IC50 of 64nM for inhibition of LTB4 production in human whole blood; a new once" daily oral anti-inflammatory drug in development for treatment of cystic fibrosis (CF) and other diseases. Cystic Fibrosis, Phase 2 Clinical